Carvedilol
Product Images NDC 67296-1900

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 67296-1900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-00)

Carvedilol Tablets, USP 12.5 mg label featuring 1000 tablets in the package. The label includes storage instructions below 30°C, a warning about the seal under the cap, and directs to the prescribing information for dosage. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. The label shows the NDC 72888-036-00 and the Advagen logo.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-01)

Label for Carvedilol Tablets USP 12.5 mg, containing 100 tablets per package. The label includes storage instructions, dosage advisory, barcode, and is distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited, with manufacturing license number KD-682. It is marked Rx Only for prescription use.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-30)

Label for Carvedilol Tablets USP 12.5 mg, package containing 30 tablets. The label includes storage instructions, dispensing advisories, and a barcode. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. Includes NDC 72888-036-30 and states 'Rx Only' and 'Do not accept if seal under cap is missing or broken.'*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-05)

Carvedilol Tablets, USP 12.5 mg label showing a bottle container with 500 tablets. The label contains storage instructions, dispensing advice, and manufacturer details. Distributed by Advagen Pharma Limited in New Jersey, and manufactured by Rubicon Research Private Limited in India. The label includes the product NDC 72888-036-05 and indicates prescription use only.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-00)

Label for Carvedilol Tablets, USP 25 mg, package size 1000 tablets. The label includes storage instructions to keep below 30°C and protect from moisture. The product is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited, India. The label features barcodes, a note about dosage, and a caution about the product seal.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-01)

Label for Carvedilol Tablets USP 25 mg, containing 100 tablets. The label includes storage instructions, a warning not to accept if seal is broken, and manufacturer details: Rubicon Research Private Limited, India, with distribution by Advagen Pharma Limited, USA. The label also displays barcode and batch information.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-30)

Carvedilol Tablets, USP 25 mg bottle label showing a 30-tablet count. The label includes storage instructions to keep below 30°C and protect from moisture, with warnings about the seal under the cap. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-05)

Carvedilol Tablets, USP 25 mg label showing 500 tablets, Rx only. The label includes storage instructions to keep below 30°C and protect from moisture, with a warning about the seal under the cap. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. The label features barcodes and revision information dated 07/21.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-00)

This is a packaging label for Carvedilol Tablets, USP 3.125 mg, with a quantity of 1000 tablets. The label includes storage instructions, a warning about seal integrity, and directs to accompanying prescribing information for dosage. Distributed by Advagen Pharma Limited in New Jersey, manufactured by Rubicon Research Private Limited in India. The label shows NDC 72888-034-00 and includes barcodes and revision date 07/21.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-01)

Carvedilol Tablets, USP 3.125 mg label showing a package of 100 tablets. The label includes storage instructions, a warning about the safety seal, dosage reference, and distribution and manufacturing information by Advagen Pharma Limited and Rubicon Research Private Limited. Barcode and revision date are also visible.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-30)

Label for Carvedilol Tablets, USP 3.125 mg, with a quantity of 30 tablets. The label includes storage instructions, a barcode, and information about dispensing and dosage. It indicates distribution by Advagen Pharma Limited and manufacturing by Rubicon Research Private Limited. The label shows NDC 72888-034-30 and a revision date of 07/21.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-05)

Label for Carvedilol Tablets USP 3.125 mg, containing 500 tablets. The label includes storage instructions to keep below 30°C (86°F) and protect from moisture, along with warnings about seal integrity. It shows the NDC 72888-034-05 and lists Advagen Pharma Limited as distributor and Rubicon Research Private Limited as manufacturer.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-00)

Label for Carvedilol Tablets USP 6.25 mg showing a package size of 1000 tablets. The label includes storage instructions and a notice to check the seal under the cap. It lists Advagen Pharma Limited as the distributor and Rubicon Research Private Limited as the manufacturer. The label contains barcodes and the product is marked Rx Only.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-01)

Carvedilol Tablets USP 6.25 mg label for a 100-tablet bottle. The label includes storage instructions, dosage advice to see prescribing information, and warnings about seal integrity. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label also displays the NDC 72888-035-01 and barcode.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-30)

Label for Carvedilol Tablets USP 6.25 mg, containing 30 tablets. The label includes storage instructions, manufacturer and distributor details, barcode, and a caution about the seal under the cap. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-05)

Label for Carvedilol Tablets USP 6.25 mg, containing 500 tablets. The label includes storage instructions, safety seals notice, and directions to see prescribing information for dosage. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. The label displays the NDC 72888-035-05 and features Advagen logo.*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

A line graph comparing % mortality over a 21-month period between Carvedilol and placebo groups. The x-axis represents months, and the y-axis shows % mortality, with Carvedilol demonstrating consistently lower mortality than placebo. A p-value of 0.0014 is indicated, highlighting statistical significance.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

A forest plot showing hazard ratios for CARVEDILOL treatment outcomes across various subgroups, including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use, with confidence intervals displayed for each group and an overall effect line at hazard ratio 1.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

A line graph comparing mortality percentage over 24 months between Carvedilol-treated and placebo groups. The y-axis shows % mortality from 0 to 30%, and the x-axis shows time in months from 0 to 24. The Carvedilol group consistently shows lower mortality than placebo, with a P value of 0.03 indicated.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

A hazard ratio forest plot displaying comparative data for multiple patient subgroups, including age, sex, timing of randomization post-myocardial infarction (MI), prior beta-blocker use, Killip classification, thrombolytic therapy, and clinical factors such as congestive heart failure, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Each subgroup is plotted with confidence intervals against hazard ratios for all patients.*

FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

Chemical structure diagram of Carvedilol showing the molecular arrangement of its constituent atoms and bonds, including the characteristic indole and phenyl groups along with functional hydroxyl and ether groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.